Ashtrom Residential: Sales Are Holding, but at What Financing Cost?
Ashtrom Residential kept revenue at a high level in 2025, but it did so with heavier contractor-loan usage, larger interest subsidies, and bigger revenue reductions from financing components. That matters because the forward project base is very large, so 2026 is not just about how many apartments are sold, but how much of those sales converts into cash without further financing strain.
The main article on Ashtrom Group argued that the core problem is not a lack of operating engines. It is that free cash is still lagging behind the breadth of activity. In residential development, that point only appeared in compressed form. This follow-up isolates the more specific question inside Ashtrom Residential: did 2025 preserve healthy sales, or mostly preserve the sales headline while a financing cost was pushed deeper into the transaction itself?
That is not semantics. Ashtrom Residential sits on a very large base of housing units in different stages, plus a large pool of future revenue and gross profit that has not yet been recognized. Once the forward pipe is that large, a change in sale terms is no longer a marketing footnote. It becomes a question of earnings quality, backlog quality, and cash timing for the next few years.
The 2025 numbers show a mixed picture. Revenue from the residential segment rose to ILS 840 million from ILS 789 million a year earlier. But units sold, including partners, fell to 350 from 401, segment profit fell to ILS 105 million from ILS 123 million, and gross profit edged down to ILS 191 million from ILS 192 million. The headline held up. The quality underneath it weakened.
Sales Held, but Not on the Same Terms
The simplest way to read 2025 is to look not only at revenue, but at the relationship between sale pace, margin, and the support the company had to give the buyer.
| Metric | 2024 | 2025 | What it means |
|---|---|---|---|
| Units sold, including partners | 401 | 350 | Volume fell by about 12.7%, so demand did not truly strengthen |
| Residential revenue | ILS 789 million | ILS 840 million | Revenue held up and even rose despite lower volume |
| Gross profit | ILS 192 million | ILS 191 million | Almost no gross-profit improvement despite higher revenue |
| Gross margin | 24.3% | 22.7% | Compression already moved into the quality of the transaction itself |
| Segment profit | ILS 123 million | ILS 105 million | The decline is sharper here, which makes it hard to argue the sales mix was preserved at the same quality |
This does not mean 2025 sales were weak. The point is more specific, and more important. Ashtrom Residential managed to keep activity at a fairly high level, but it did so while the transaction itself became more generous to the buyer and less clean for the developer. That is exactly where a residential developer can still look stable from the outside while starting to pay for the sale through margin, through cash timing, or through both.
The Financing Cost Is No Longer Marginal
This is where the annual report becomes unusually direct. Ashtrom Residential says that during the period it marketed some apartments under 20/75/5 and 15/80/5 structures, subsidized interest payments on buyer loans, and sold units without linkage to the construction-input index. The company explicitly says these arrangements were a response to market conditions and to competition from similar sales campaigns in competing projects.
The important point is that the cost of that choice is already measurable, not just hinted at in the tone of the disclosure.
In 2024 and 2025, 5 and 67 units, respectively, were sold with contractor loans. On those loans, Ashtrom Residential paid banks mortgage interest of about ILS 0.8 million in 2024 and ILS 9.6 million in 2025. At the same time, for flexible contracts such as 20/75/5 and 15/80/5, the company calculated the effect of a significant financing component through a reduction in sale prices for revenue-recognition purposes, amounting to about ILS 5.2 million in 2024 and ILS 13.9 million in 2025.
This is no longer a footnote. Across the two components the company does quantify, the identified financing price reached roughly ILS 23.5 million in 2025. And even that is not necessarily the whole story, because the company also mentions non-indexed sales without giving a separate cost estimate. So it would be wrong to claim with certainty that the true cost is higher, but it is correct to say that the identified cost is only a partial view.
This is the line between ordinary growth and growth achieved through concession. If a residential developer sells more at full economic value, that is genuine demand strength. If it keeps the pace by deferring payment, subsidizing interest, and waiving indexation, the question shifts from the signed number to who is financing the transaction until delivery.
The company does add an important offsetting point. It says exposure to cancellations under these structures is limited, partly because of past experience and partly because mortgage banks underwrite the buyers. That is a fair counter-argument, and it should be kept in view. But even if underwriting reduces cancellation risk, it does not eliminate the wider economic issue. A transaction can remain valid and still be a lower-quality transaction.
There is one more detail worth noticing. On March 23, 2025, a draft temporary directive by the Supervisor of Banks was published, through the end of 2026, aimed at transactions where a meaningful portion of the consideration is deferred until delivery, and at contractor-subsidized bullet or balloon mortgages. The report does not say Ashtrom Residential breached those limits, and it would be wrong to jump to that conclusion. But the fact that the company chose to describe this backdrop inside the sales-arrangement discussion shows that the issue has already moved from marketing into financing and regulation.
2026 Is a Conversion Test, Not Only a Demand Test
To see why these structures matter now, they need to be connected to the forward pipe.
In the investor presentation, Ashtrom Residential presents 18,244 housing units in different stages. Within that broader picture, there are still 4,476 units available for marketing, ILS 14.772 billion of future revenue not yet recognized, and ILS 2.635 billion of future gross profit not yet recognized, all on Ashtrom Residential’s share basis and excluding partners and landowners. In other words, the issue is not whether the company has enough to sell. The issue is on what terms it will sell, and how quickly reported profit will be accompanied by real cash.
| Forward-pipe metric | Scale | Why it matters |
|---|---|---|
| Housing units in different stages | 18,244 | A very large pipeline that gives visibility, but also magnifies the importance of sales quality |
| Units available for marketing | 4,476 | Meaningful inventory the company still has to convert into contracts on economically reasonable terms |
| Future revenue not yet recognized | ILS 14.772 billion | There is a large accounting future, but that alone says nothing about conversion quality |
| Future gross profit not yet recognized | ILS 2.635 billion | This is profit potential, not a guarantee of cash at the same quality |
The annual report adds a more revealing layer. Within Ashtrom Residential’s projects under construction, the total number of housing units rose to 818 from 507, and the number of units still lacking binding sale agreements rose to 623 from 412. At the same time, the number of binding sale agreements signed during the period rose only to 99 from 95.
This is one of the most important data points in the whole evidence set. It does not prove by itself that the financing-heavy promotions were the only reason unsigned inventory expanded. But it does show that while the construction-stage pipe grew sharply, signing pace did not accelerate by nearly the same amount. That makes the move toward more generous financing structures look less like a one-off marketing tactic and more like a tool used to preserve pace in a tougher competitive environment.
The forward recognition schedule sharpens the point. As of year-end 2025, Ashtrom Residential showed ILS 568.45 million of revenue to be recognized from binding sale contracts, against ILS 721.78 million of deposits and payments expected under those same contracts. Only about ILS 395.5 million of those expected payments is scheduled for 2026, while the remaining roughly ILS 326.3 million is due from 2027 onward. That does not prove all of the delay stems from flexible structures, but it does remind the reader why sale terms matter more than the headline unit count. Cash does not necessarily arrive together with the sale.
Put differently, 2026 will not be only a demand test. It will be a conversion test. If Ashtrom Residential can preserve sales without deepening buyer support, and if unsigned construction-stage inventory starts to come down, 2025 can be read as a reasonable bridge year. But if the company has to expand contractor loans, flexible contracts, and non-indexed sales further just to move inventory, then 2025 will look less like stability and more like the year sale quality had already begun to erode faster than the headline suggested.
The Tax Ruling May Improve the Headline, but It Does Not Fix the Core Issue
In February 2026, Ashtrom Residential received a ruling from the real-estate taxation appeals committee that accepted its appeals against the tax authorities and held that winning certain Price for Occupant tenders and signing the related contractual framework do not constitute acquisition of a real-estate right. Based on that ruling, the company says that if the decision stands and is implemented, it expects a purchase-tax refund and recognition of roughly ILS 30 million of profit on projects already booked through the income statement.
That is a positive event, but it needs to stay in its place. First, the company itself stresses that timing, final scope, profit-recognition timing, and accounting impact depend on possible further proceedings and on tax-authority decisions. Second, even if the profit is recognized in full, it says nothing new about the quality of 2025 sales or the financing cost required to keep marketing moving. It can improve the near-term earnings headline, but it does not solve the underlying operating question.
So from the reader’s perspective, two different stories should not be blended together. The court ruling is a positive legal and accounting trigger. Sales quality is an operating and financing issue. Combining them into one neat narrative would make the story cleaner than the evidence allows.
Conclusions
The continuation thesis is straightforward: Ashtrom Residential did not lose the market, but it is already paying to keep it. That shows up in the jump in contractor-loan usage, the interest cost the company is now absorbing, the larger revenue reduction from financing components, and the fact that it also mentions non-indexed sales without quantifying the cost.
What makes this important is scale. If this were a small issue at the edge of the pipe, it could be dismissed as a tactical promotion. But with 18,244 units in different stages, 4,476 units available for marketing, and ILS 14.772 billion of future revenue still unrecognized, sales quality becomes a central question for 2026.
The strongest counter-thesis is that the company explicitly says cancellation exposure is limited, that the banks underwrite buyers, and that financing promotions are simply temporary market conditions rather than a meaningful signal about project quality. That is a legitimate argument. But it will hold only if 2026 shows two things at once: preserved sale pace and lower dependence on buyer financing support.
If that happens, 2025 will look like a reasonable transition year. If it does not, the market may conclude that the real issue is not weak demand, but demand that needs too much support to stay alive.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.